24th Apr 2012 12:00
24 April 2012
Plethora Solutions Holdings PLC
("Plethora" or the "Company")
Change of Registered Office
The Company announces that, with immediate effect, its registered address has changed to: 1st Floor, St Andrew's House, 18-20 St Andrew Street, London, EC4A 3AG
All telephone and fax numbers remain the same.
-Ends-
Enquiries:
Plethora Solutions Ronald Openshaw, CEO | Tel : +44(0) 20 3077 5400 |
Daniel Stewart (Nomad & Joint Broker) David Hart / James Felix (Nomad) Martin Lampshire (Broker) | Tel : +44(0) 20 7776 6550
|
Hybridan LLP (Joint Broker) Claire Louise Noyce/ Deepak Reddy | Tel: +44(0) 20 7947 4350
|
Newgate Threadneedle (Financial PR) Guy McDougall/ Graham Herring | Tel: +44(0) 20 7653 9842
|
About Plethora:
Plethora is focussed on the development and marketing of products for the treatment of urological disorders. The Company isfocussed on: (i) driving the development of its speciality sales and marketing business, The Urology Company; and (ii) seeking to increase the value of its development assetsthe most advanced of which is PSD502 for the treatment of premature ejaculation.
Plethora's subsidiary, The Urology Company Limited, established in 2009, markets and distributes a range of branded and generic pharmaceutical products, pharmaceutical specials, medical devices and nutritional supplements for the treatment of urology, andrology and obstetric conditions. Its products fall into two categories (i) Professional - where a physician, nurse or other healthcare professional makes a prescribing decision and include Striant® SR, Urolieve®, Hyalofemme® and Dianatal®; and (ii) Consumer - where the consumer/patient makes a buying decision and include Hyalofemme®, Multi-Gyn®, Multi-Mam® and hI-Cran®.
The Company is headquartered in the UK and is listed on the London Stock Exchange (AIM: PLE.L). Further information is available at www.plethorasolutions.co.uk and www.theurologyco.com
Related Shares:
Plethora Solutions Holdings Plc